0001846802-21-000001.txt : 20210224
0001846802-21-000001.hdr.sgml : 20210224
20210224154214
ACCESSION NUMBER: 0001846802-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210224
DATE AS OF CHANGE: 20210224
EFFECTIVENESS DATE: 20210224
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ribogenics, Inc.
CENTRAL INDEX KEY: 0001846802
IRS NUMBER: 824855128
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-390403
FILM NUMBER: 21672386
BUSINESS ADDRESS:
STREET 1: C/O SGRV P.C. 1635 MARKET STREET
STREET 2: 7TH FL
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 9194127411
MAIL ADDRESS:
STREET 1: C/O SGRV P.C. 1635 MARKET STREET
STREET 2: 7TH FL
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
D
1
primary_doc.xml
X0708
D
LIVE
0001846802
Ribogenics, Inc.
C/O SGRV P.C. 1635 MARKET STREET
7TH FL
PHILADELPHIA
PA
PENNSYLVANIA
19103
9194127411
DELAWARE
None
None
Corporation
true
2018
Yves
Ribeill
c/o SGRV P.C.
1635 Market Street, 7th Floor
Philadelphia
PA
PENNSYLVANIA
19103
Executive Officer
Laurent
Arthaud
c/o SGRV P.C.
1635 Market Street, 7th Floor
Philadelphia
PA
PENNSYLVANIA
19103
Director
Serge
Braun
c/o SGRV P.C.
1635 Market Street, 7th Floor
Philadelphia
PA
PENNSYLVANIA
19103
Director
Wei
Zhang
c/o SGRV P.C.
1635 Market Street, 7th Floor
Philadelphia
PA
PENNSYLVANIA
19103
Director
Biotechnology
No Revenues
- 06b
false
2021-02-10
false
true
false
0
8000000
6025000
1975000
The Total Amount Sold includes amounts to be purchased upon the completion of certain milestone events.
false
3
0
0
0
false
Ribogenics, Inc.
Yves Ribeill
Yves Ribeill
CEO & President
2021-02-24